or
Bookmark and Share
Method of using hydrazone containing ligands and metal complexes thereof
   
Document Number
US Patent 5651954
Issued Date
July 29, 1997
Link
Inventors
Map
Abstract
Novel compounds of the formula ##STR1## where G.sup.1 and G.sup.2 are each independently --OH or --N(R.sup.2).sub.2, provided that at least one of G.sup.1 and G.sup.2 is --N(R.sup.2).sub.2, where each R.sup.2 is independently hydrogen, alkyl, aryl, acyl or --(A).sub.p --R.sup.a and the other variables are as defined in the specification and claims, and novel complexes of these compounds with metals are useful in diagnostic and therapeutic methods.
Drawing
Method of using hydrazone containing ligands and metal complexes thereof - US Patent 5651954 Drawing
Drawing from US Patent 5651954
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
6
Comments:
no comments yet
Owner
Published
July 29, 1997
Application Number
08/473,563
Filed
June 6, 1995
US Classification
424/1.65  
Int'l Classification
C07C   251/76   (20060101)   C07C   251/00   (20060101)   C07B   59/00   (20060101)   A61K   51/04   (20060101)   A61K   51/02   (20060101)   C07F   13/00   (20060101)  
Examiner
Assistant Examiner
Parent Case
This is a divisional of application Ser. No. 08/180,260, filed Jan. 12, 1994 now abandoned.
USPTO Field of Search
424/1.65  
Related Patents
6359120 - Rhenium and technetium complexes containing a hypoxia-localizing moiety - Owned by Bracco International B.V. (Amsterdam,NL)

Novel methods, processes and metal complexes attached to a hypoxia-localizing moiety comprising a metal, preferably radionuclide of rhenium or technetium; a hypoxia-localizing moiety; and, a complexing ligand, wherein said ligand and said radionuclide combined have cell membrane permeabilities greater than that of sucrose, are disclosed.

5993774 - Metal-oxime chelates for use as radiopharmaceutical agents - Owned by Amersham International plc (GB)

Novel metal chelating compounds, and radiometal, e.g., technetium-99m complexes thereof. The compounds can be used to radiolabel small biologically active species with minimal effect on their biodistribution and activity. The compounds have formula (a) or (b): ##STR1## where Z is (CR.sub.2).sub.n or (CR).sub.n, n is 2 or 3, X is a ligand comprising S, N or O, each R is H or C1-C20 substituted or unsubstituted hydrocarbon group, provided that 1-3 CR.sub.2 groups represent a CO (amide) moiety, and provided that 1-3 R may each comprise a targeting group and/or a protein reactive functionality.

6699458 - Rhenium and technetium complexes containing a hypoxia-localizing moiety - Owned by Bracco International B.V. (Amsterdam,NL)

Novel methods, processes and metal complexes attached to a hypoxia-localizing moiety comprising a metal, preferably radionuclide of rhenium or technetium; a hypoxia-localizing moiety; and, a complexing ligand, wherein said ligand and said radionuclide combined have cell membrane permeabilities greater than that of sucrose, are disclosed.

6958141 - Rhenium and technetium complexes containing a hypoxia-localizing moiety - Owned by Bracco International B.V. (Amsterdam,NL)

Novel methods, processes and metal complexes attached to a hypoxia-localizing moiety comprising a metal, preferably radionuclide of rhenium or technetium; a hypoxia-localizing moiety; and, a complexing ligand, wherein said ligand and said radionuclide combined have cell membrane permeabilities greater than that of sucrose, are disclosed.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us